imited skin areas and vitamin D

Completed

• Conditions: Topic: Dermatology; Subtopic: Skin (all Subtopics); Disease: Dermatology; Skin and Connective Tissue Diseases

• Registration Number: ISRCTN91255549
• Lead Sponsor: niversity of Manchester

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-02-04
• Last Update Posted: 6 July 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Healthy, ambulant, male and female adults aged 20-60 years
2. White Caucasian (sun-reactive skin type I-IV)
3. Willing and capable of participating to the extent and degree required by the protocol

Exclusion Criteria

1. Sunbathing or sunbed use in the last 3 months
2. Taking photoactive medication
3. Taking vitamin D, fish oil or calcium supplements
4. History of skin cancer or photosensitivity disorder
5. Pregnancy/lactation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure is serum 25-hydroxyvitamin D (25(OH)D) concentration which is measured at baseline, then weekly up to 6 weeks. Further samples to be taken at weeks 8, 10 and 12. Serum 25(OH)D is measured by liquid chromatography tandem mass spectrophotometry (LC-MS/MS).